ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

UICC Announces Grant Programs to Continue

April 15, 1977

Survey Finds Misconceptions About Cancer Worldwide

August 29, 2008

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

March 31, 2000

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Litton’s New Fredrick Award Could Total Around $30 Million

July 30, 1976